These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18760278)

  • 1. PD-1 ligand expression by human colonic myofibroblasts/fibroblasts regulates CD4+ T-cell activity.
    Pinchuk IV; Saada JI; Beswick EJ; Boya G; Qiu SM; Mifflin RC; Raju GS; Reyes VE; Powell DW
    Gastroenterology; 2008 Oct; 135(4):1228-1237, 1237.e1-2. PubMed ID: 18760278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
    Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
    Front Immunol; 2018; 9():1125. PubMed ID: 29910803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR4 activation enhances the PD-L1-mediated tolerogenic capacity of colonic CD90+ stromal cells.
    Beswick EJ; Johnson JR; Saada JI; Humen M; House J; Dann S; Qiu S; Brasier AR; Powell DW; Reyes VE; Pinchuk IV
    J Immunol; 2014 Sep; 193(5):2218-29. PubMed ID: 25070848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human colonic myofibroblasts promote expansion of CD4+ CD25high Foxp3+ regulatory T cells.
    Pinchuk IV; Beswick EJ; Saada JI; Boya G; Schmitt D; Raju GS; Brenmoehl J; Rogler G; Reyes VE; Powell DW
    Gastroenterology; 2011 Jun; 140(7):2019-30. PubMed ID: 21376048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subepithelial myofibroblasts are novel nonprofessional APCs in the human colonic mucosa.
    Saada JI; Pinchuk IV; Barrera CA; Adegboyega PA; Suarez G; Mifflin RC; Di Mari JF; Reyes VE; Powell DW
    J Immunol; 2006 Nov; 177(9):5968-79. PubMed ID: 17056521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-L1 expression on human ocular cells and its possible role in regulating immune-mediated ocular inflammation.
    Yang W; Li H; Chen PW; Alizadeh H; He Y; Hogan RN; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):273-80. PubMed ID: 18791172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
    Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
    J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human decidual stromal cells suppress cytokine secretion by allogenic CD4+ T cells via PD-1 ligand interactions.
    Nagamatsu T; Schust DJ; Sugimoto J; Barrier BF
    Hum Reprod; 2009 Dec; 24(12):3160-71. PubMed ID: 19729380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8(+) T cells from HIV-1-infected individuals.
    Breton G; Yassine-Diab B; Cohn L; Boulassel MR; Routy JP; Sékaly RP; Steinman RM
    J Clin Immunol; 2009 Sep; 29(5):637-45. PubMed ID: 19562472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD90(+) stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer.
    Huynh PT; Beswick EJ; Coronado YA; Johnson P; O'Connell MR; Watts T; Singh P; Qiu S; Morris K; Powell DW; Pinchuk IV
    Int J Cancer; 2016 Apr; 138(8):1971-81. PubMed ID: 26595254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen-specific CD8+ T cells.
    Hobo W; Maas F; Adisty N; de Witte T; Schaap N; van der Voort R; Dolstra H
    Blood; 2010 Nov; 116(22):4501-11. PubMed ID: 20682852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-1 on immature and PD-1 ligands on migratory human Langerhans cells regulate antigen-presenting cell activity.
    Peña-Cruz V; McDonough SM; Diaz-Griffero F; Crum CP; Carrasco RD; Freeman GJ
    J Invest Dermatol; 2010 Sep; 130(9):2222-30. PubMed ID: 20445553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.
    Carter L; Fouser LA; Jussif J; Fitz L; Deng B; Wood CR; Collins M; Honjo T; Freeman GJ; Carreno BM
    Eur J Immunol; 2002 Mar; 32(3):634-43. PubMed ID: 11857337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands.
    Kinter AL; Godbout EJ; McNally JP; Sereti I; Roby GA; O'Shea MA; Fauci AS
    J Immunol; 2008 Nov; 181(10):6738-46. PubMed ID: 18981091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of CD4⁺ T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis.
    Hashimoto N; Shimoda S; Kawanaka H; Tsuneyama K; Uehara H; Akahoshi T; Kinjo N; Taketomi A; Shirabe K; Akashi K; Lleo A; Ansari AA; Gershwin ME; Maehara Y
    Clin Exp Immunol; 2011 Aug; 165(2):243-50. PubMed ID: 21615390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses.
    Bennett F; Luxenberg D; Ling V; Wang IM; Marquette K; Lowe D; Khan N; Veldman G; Jacobs KA; Valge-Archer VE; Collins M; Carreno BM
    J Immunol; 2003 Jan; 170(2):711-8. PubMed ID: 12517932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation.
    Kanai T; Totsuka T; Uraushihara K; Makita S; Nakamura T; Koganei K; Fukushima T; Akiba H; Yagita H; Okumura K; Machida U; Iwai H; Azuma M; Chen L; Watanabe M
    J Immunol; 2003 Oct; 171(8):4156-63. PubMed ID: 14530338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1+ T helper 1 cells by a contact-dependent mechanism.
    Sugita S; Usui Y; Horie S; Futagami Y; Yamada Y; Ma J; Kezuka T; Hamada H; Usui T; Mochizuki M; Yamagami S
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):263-72. PubMed ID: 18775867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.